StockData
Cronos Group Inc. logo

Cronos Group Inc. (CRON) stock

CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.19−0.08 (-2.45%)

Close on Nov 17, 2026Market cap $1.18BP/E 15.9Yield –

Cronos pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cronos's pe ratio was 17.3× on Nov 11, 2026, against 52.0× a year earlier. Over the last 3 years it ranged from 1.7× to 284.0×, with a median of 16.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.3×−9.1
2025Dec 31, 202526.3×−16.8
2021Jan 29, 202143.1×+14.2
2020Dec 31, 202028.9×–

More Cronos figures

See a number that looks wrong?